Benzinga | Mar 8, 2021 09:53AM EST

Stephens & Co. Upgrades Bio-Techne to Overweight, Raises Price Target to $425

Stephens & Co. analyst Jacob Johnson upgrades Bio-Techne (NASDAQ:TECH) from Equal-Weight to Overweight and raises the price target from $380 to $425.